Screening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometry

Biochemistry

Volumn 49, Issue 17, 2010, Pages 3743-3752

  Naimy, Hicham ^a   Leymarie, Nancy ^a   Zaia, Joseph ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT ACTIVITIES; BINDING PROTEINS; BIOLOGICAL ACTIVITIES; EXTRACELLULAR MATRICES; FINE STRUCTURES; GLYCOSAMINOGLYCANS; GROWTH FACTOR; HEPARAN SULFATES; LOW-ENERGY COLLISION-INDUCED DISSOCIATION; MAMMALIAN CELLS; MAST CELLS; PROTEIN BINDERS; PROTEIN BINDING; RECEPTOR INTERACTION; TANDEM MASS SPECTROMETRY;

BINDING ENERGY; BIOACTIVITY; BIOCHEMISTRY; LIQUID CHROMATOGRAPHY; MAMMALS; MASS SPECTROMETRY; OLIGOSACCHARIDES; POLYSACCHARIDES; PROTEINS;

HYDRAULIC STRUCTURES;

ANTICOAGULANT AGENT; HEPARAN SULFATE; HEPARAN SULFATE OCTASACCHARIDE; HEPARIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; COLLISIONALLY ACTIVATED DISSOCIATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG STRUCTURE; ENERGY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; TANDEM MASS SPECTROMETRY;

ANIMALS; ANTICOAGULANTS; ANTITHROMBIN III; CHROMATOGRAPHY, LIQUID; FACTOR XA; HEPARITIN SULFATE; HYDROLYSIS; INTESTINAL MUCOSA; OLIGOSACCHARIDES; SWINE; TANDEM MASS SPECTROMETRY;

MAMMALIA;

EID: 77951684925     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi100135d     Document Type: Article

References (61)

1. Varki, A., Cummings, R., Esko, J., Freeze, H., Hart, G., and Marth, G. (1999) Essentials of Glycobiology, Cold Spring Harbor Laboratory Press, Plainview, NY.
2. Ai, X., Do, A. T., Lozynska, O., Kusche-Gullberg, M., Lindahl, U., and Emerson, C. P., Jr. (2003) QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling J. Cell Biol. 162, 341-351
3. Vlodavsky, I., Goldshmidt, O., Zcharia, E., Atzmon, R., Rangini-Guatta, Z., Elkin, M., Peretz, T., and Friedmann, Y. (2002) Mammalian heparanase: Involvement in cancer metastasis, angiogenesis and normal development Semin. Cancer Biol. 12, 121-129
4. Carlsson, P., Presto, J., Spillmann, D., Lindahl, U., and Kjellen, L. (2008) Heparin/heparan sulfate biosynthesis: Processive formation of N-sulfated domains J. Biol. Chem. 283, 20008-20014
5. Fransson, L. A., Belting, M., Cheng, F., Jonsson, M., Mani, K., and Sandgren, S. (2004) Novel aspects of glypican glycobiology Cell. Mol. Life Sci. 61, 1016-1024
6. Belting, M., Mani, K., Jonsson, M., Cheng, F., Sandgren, S., Jonsson, S., Ding, K., Delcros, J. G., and Fransson, L. A. (2003) Glypican-1 is a vehicle for polyamine uptake in mammalian cells: A pivital role for nitrosothiol-derived nitric oxide J. Biol. Chem. 278, 47181-47189
7. Bernfield, M., Gotte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., and Zako, M. (1999) Functions of cell surface heparan sulfate proteoglycans Annu. Rev. Biochem. 68, 729-777
8. Bishop, J. R., Schuksz, M., and Esko, J. D. (2007) Heparan sulphate proteoglycans fine-tune mammalian physiology Nature 446, 1030-1037
9. Esko, J. D. and Selleck, S. B. (2002) Order out of chaos: Assembly of ligand binding sites in heparan sulfate Annu. Rev. Biochem. 71, 435-471
10. Lindahl, U., Thunberg, L., Backstrom, G., Riesenfeld, J., Nordling, K., and Bjork, I. (1984) Extension and structural variability of the antithrombin-binding sequence in heparin J. Biol. Chem. 259, 12368-12376
11. 13C nuclear-magnetic-resonance studies Biochem. J. 197, 599-609
12. Thunberg, L., Backstrom, G., and Lindahl, U. (1982) Further characterization of the antithrombin-binding sequence in heparin Carbohydr. Res. 100, 393-410
13. Atha, D. H., Stephens, A. W., Rimon, A., and Rosenberg, R. D. (1984) Sequence variation in heparin octasaccharides with high affinity for antithrombin III Biochemistry 23, 5801-5812 (Pubitemid 15189730)
14. Atha, D. H., Lormeau, J. C., Petitou, M., Rosenberg, R. D., and Choay, J. (1985) Contribution of monosaccharide residues in heparin binding to antithrombin III Biochemistry 24, 6723-6729 (Pubitemid 16207156)
15. Seyrek, E., Dubin, P. L., and Henriksen, J. (2007) Nonspecific electrostatic binding characteristics of the heparin-antithrombin interaction Biopolymers 86, 249-259
16. Maccarana, M., Casu, B., and Lindahl, U. (1993) Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor J. Biol. Chem. 268, 23898-23905
17. Habuchi, H., Suzuki, S., Saito, T., Tamura, T., Harada, T., Yoshida, K., and Kimata, K. (1992) Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor Biochem. J. 285 (Part 3) 805-813
18. Turnbull, J. E., Fernig, D. G., Ke, Y., Wilkinson, M. C., and Gallagher, J. T. (1992) Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate J. Biol. Chem. 267, 10337-10341
19. Kreuger, J., Prydz, K., Pettersson, R. F., Lindahl, U., and Salmivirta, M. (1999) Characterization of fibroblast growth factor 1 binding heparan sulfate domain Glycobiology 9, 723-729
20. Jastrebova, N., Vanwildemeersch, M., Rapraeger, A. C., Gimenez-Gallego, G., Lindahl, U., and Spillmann, D. (2006) Heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors J. Biol. Chem. 281, 26884-26892
21. Lindahl, U. (2007) Heparan sulfate-protein interactions: A concept for drug design? Thromb. Haemostasis 98, 109-115
22. Kreuger, J., Matsumoto, T., Vanwildemeersch, M., Sasaki, T., Timpl, R., Claesson-Welsh, L., Spillmann, D., and Lindahl, U. (2002) Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function EMBO J. 21, 6303-6311
23. Stringer, S. E. and Gallagher, J. T. (1997) Specific binding of the chemokine platelet factor 4 to heparan sulfate J. Biol. Chem. 272, 20508-20514
24. Spillmann, D., Witt, D., and Lindahl, U. (1998) Defining the interleukin-8-binding domain of heparan sulfate J. Biol. Chem. 273, 15487-15493
25. Lortat-Jacob, H., Turnbull, J. E., and Grimaud, J. A. (1995) Molecular organization of the interferon γ-binding domain in heparan sulphate Biochem. J. 310 (Part 2) 497-505
26. Yu, Y., Sweeney, M. D., Saad, O. M., and Leary, J. A. (2006) Potential inhibitors of chemokine function: Analysis of noncovalent complexes of CC chemokine and small polyanionic molecules by ESI FT-ICR mass spectrometry J. Am. Soc. Mass Spectrom. 17, 524-535
27. Harmer, N. J., Robinson, C. J., Adam, L. E., Ilag, L. L., Robinson, C. V., Gallagher, J. T., and Blundell, T. L. (2006) Multimers of the fibroblast growth factor (FGF)-FGF receptor-saccharide complex are formed on long oligomers of heparin Biochem. J. 393, 741-748
28. Yu, Y., Sweeney, M. D., Saad, O. M., Crown, S. E., Hsu, A. R., Handel, T. M., and Leary, J. A. (2005) Chemokine-glycosaminoglycan binding: Specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry J. Biol. Chem. 280, 32200-32208
29. Maccarana, M. and Lindahl, U. (1993) Mode of interaction between platelet factor 4 and heparin Glycobiology 3, 271-277
30. Schenauer, M. R., Yu, Y., Sweeney, M. D., and Leary, J. A. (2007) CCR2 chemokines bind selectively to acetylated heparan sulfate octasaccharides J. Biol. Chem. 282, 25182-25188
31. Abzalimov, R. R., Dubin, P. L., and Kaltashov, I. A. (2007) Glycosaminoglycans as naturally occurring combinatorial libraries: Developing a mass spectrometry-based strategy for characterization of anti-thrombin interaction with low molecular weight heparin and heparin oligomers Anal. Chem. 79, 6055-6063
32. Fermas, S., Gonnet, F., Varenne, A., Gareil, P., and Daniel, R. (2007) Frontal analysis capillary electrophoresis hyphenated to electrospray ionization mass spectrometry for the characterization of the antithrombin/heparin pentasaccharide complex Anal. Chem. 79, 4987-4993
33. Ruiz-Calero, V., Moyano, E., Puignou, L., and Galceran, M. T. (2001) Pressure-assisted capillary electrophoresis-electrospray ion trap mass spectrometry for the analysis of heparin depolymerised disaccharides J. Chromatogr. 914, 277-291
34. Pope, R. M., Raska, C. S., Thorp, S. C., and Liu, J. (2001) Analysis of heparan sulfate oligosaccharides by nano-electrospray ionization mass spectrometry Glycobiology 11, 505-513
35. Zaia, J. and Costello, C. E. (2003) Tandem mass spectrometry of sulfated heparin-like glycosaminoglycan oligosaccharides Anal. Chem. 75, 2445-2455
36. de Agostini, A. I., Dong, J. C., de Vantery Arrighi, C., Ramus, M. A., Dentand-Quadri, I., Thalmann, S., Ventura, P., Ibecheole, V., Monge, F., Fischer, A. M., HajMohammadi, S., Shworak, N. W., Zhang, L., Zhang, Z., and Linhardt, R. J. (2008) Human follicular fluid heparan sulfate contains abundant 3-O-sulfated chains with anticoagulant activity J. Biol. Chem. 283, 28115-28124
37. Chai, W., Leteux, C., Westling, C., Lindahl, U., and Feizi, T. (2004) Relative susceptibilities of the glucosamine-glucuronic acid and N-acetylglucosamine-glucuronic acid linkages to heparin lyase III Biochemistry 43, 8590-8599
38. Sweeney, M. D., Yu, Y., and Leary, J. A. (2006) Effects of sulfate position on heparin octasaccharide binding to CCL2 examined by tandem mass spectrometry J. Am. Soc. Mass Spectrom. 17, 1114-1119
39. Meissen, J. K., Sweeney, M. D., Girardi, M., Lawrence, R., Esko, J. D., and Leary, J. A. (2009) Differentiation of 3-O-sulfated heparin disaccharide isomers: Identification of structural aspects of the heparin CCL2 binding motif J. Am. Soc. Mass Spectrom. 20, 652-657
40. Turnbull, J., Powell, A., and Guimond, S. (2001) Heparan sulfate: Decoding a dynamic multifunctional cell regulator Trends Cell Biol. 11, 75-82
41. Naimy, H., Leymarie, N., Bowman, M. J., and Zaia, J. (2008) Characterization of heparin oligosaccharides binding specifically to antithrombin III using mass spectrometry Biochemistry 47, 3155-3161
42. Ziegler, A. and Zaia, J. (2006) Size-exclusion chromatography of heparin oligosaccharides at high and low pressure J. Chromatogr. 837, 76-86
43. Damus, P. S., Hicks, M., and Rosenberg, R. D. (1973) Anticoagulant action of heparin Nature 246, 355-357
44. Bjork, I., Ylinenjarvi, K., Olson, S. T., and Bock, P. E. (1992) Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor J. Biol. Chem. 267, 1976-1982
45. Conrad, H. E. (1998) Heparin Binding Proteins, Academic Press, New York.
46. Sasisekharan, R., Raman, R., and Prabhakar, V. (2006) Glycomics approach to structure-function relationships of glycosaminoglycans Annu. Rev. Biomed. Eng. 8, 181-231
47. Gandhi, N. S. and Mancera, R. L. (2008) The structure of glycosaminoglycans and their interactions with proteins Chem. Biol. Drug Des. 72, 455-482
48. Capila, I. and Linhardt, R. J. (2002) Heparin-protein interactions Angew. Chem., Int. Ed. 41, 391-412
49. Domon, B. and Costello, C. E. (1988) A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates Glycoconjugate J. 5, 397-409
50. Desai, U. R., Wang, H. M., and Linhardt, R. J. (1993) Specificity studies on the heparin lyases from Flavobacterium heparinum Biochemistry 32, 8140-8145
51. HajMohammadi, S., Enjyoji, K., Princivalle, M., Christi, P., Lech, M., Beeler, D., Rayburn, H., Schwartz, J. J., Barzegar, S., de Agostini, A. I., Post, M. J., Rosenberg, R. D., and Shworak, N. W. (2003) Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis J. Clin. Invest. 111, 989-999
52. Zhang, L., Yoshida, K., Liu, J., and Rosenberg, R. D. (1999) Anticoagulant heparan sulfate precursor structures in F9 embryonal carcinoma cells J. Biol. Chem. 274, 5681-5691
53. Linhardt, R. J., Turnbull, J. E., Wang, H. M., Loganathan, D., and Gallagher, J. T. (1990) Examination of the substrate specificity of heparin and heparan sulfate lyases Biochemistry 29, 2611-2617
54. Liu, J. and Pedersen, L. C. (2007) Anticoagulant heparan sulfate: Structural specificity and biosynthesis Appl. Microbiol. Biotechnol. 74, 263-272
55. Hitchcock, A. M., Yates, K. E., Costello, C. E., and Zaia, J. (2008) Comparative glycomics of connective tissue glycosaminoglycans Proteomics 8, 1384-1397
56. Nadanaka, S. and Kitagawa, H. (2008) Heparan sulphate biosynthesis and disease J. Biochem. 144, 7-14
57. Sanderson, R. D., Yang, Y., Kelly, T., MacLeod, V., Dai, Y., and Theus, A. (2005) Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: Growth regulation and the prospect of new cancer therapies J. Cell. Biochem. 96, 897-905
58. Kato, M., Wang, H., Bernfield, M., Gallagher, J. T., and Turnbull, J. E. (1994) Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains J. Biol. Chem. 269, 18881-18890
59. Jayson, G. C., Lyon, M., Paraskeva, C., Turnbull, J. E., Deakin, J. A., and Gallagher, J. T. (1998) Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro J. Biol. Chem. 273, 51-57
60. Shi, X. and Zaia, J. (2009) Organ-specific heparan sulfate structural phenotypes J. Biol. Chem. 284, 11806-11814
61. Brickman, Y. G., Ford, M. D., Gallagher, J. T., Nurcombe, V., Bartlett, P. F., and Turnbull, J. E. (1998) Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development J. Biol. Chem. 273, 4350-4359